1st Quarter - Report
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$292,698
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.1319 - American Rescue Plan Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE CRANSTON | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| KATE ILAHI | — |
| AMANDA SELLERS SMITH | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.